1932

Abstract

▪ Abstract 

Studies utilizing experimental animals, epidemiological approaches, cellular models, and clinical trials all provide evidence that retinoic acid and some of its synthetic derivatives (retinoids) are useful pharmacological agents in cancer therapy and prevention. In this chapter, we first review the current knowledge of retinoic acid receptors (RARs) and their role in mediating the actions of retinoic acid. We then focus on a discussion of RARα and acute promyelocytic leukemia followed by a discussion of the role of RARs, in particular RARβ expression, in other cancer types. Loss of normal RAR function in the presence of physiological levels of RA (either due to alterations in the protein structure or level of expression) is associated with a variety of different cancers. In some cases treatment with pharmacological doses of RA can be effective.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.nutr.24.012003.132407
2004-07-14
2024-06-25
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.nutr.24.012003.132407
Loading
/content/journals/10.1146/annurev.nutr.24.012003.132407
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error